|
Anthony D. Ho, Heidelberg, Germany
Edward D. Ball, San Diego, California
Lawrence Goldstein, San Diego, California
Michael Andreeff, Houston, Texas
Edward Ball, San Diego, California
Konrad Beyreuther, Heidelberg, Germany
Maria Böhmer, Berlin, Germany
Martin Bornhäuser, Dresden, Germany
Richard Champlin, Houston, Texas
John DiPersio, St. Louis, Missouri
Peter Dreger, Heidelberg, Germany
Gerhard Ehninger, Dresden, Germany
Bernhard Eitel, Heidelberg, Germany
Peter Frankenberg, Stuttgart, Germany
Stefan Frühauf, Heidelberg, Germany
Hartmut Goldschmidt, Heidelberg, Germany
Lawrence Goldstein, San Diego, California
Martin Görner, Bielefeld, Germany
Rainer Haas, Düsseldorf, Germany
Anthony D. Ho, Heidelberg, Germany
Thomas Holstein, Heidelberg, Germany
Sheila Jasanoff, Boston, Massachusettes
Armand Keating, Toronto, Ontario
Hans-Jochem Kolb, München, Germany
Mark Levis, Baltimore, Maryland
Thomas Luft, Heidelberg, Germany
Bernhard Palsson, San Diego, California
Michael Pfreundschuh, Homburg/Saar, Germany
Michael Rieger, Heidelberg, Germany
Norbert Schmitz, Hamburg, Germany
Stefan Schönland, Heidelberg, Germany
J. R. Siewert, Heidelberg, Germany
Rainer Storb, Seattle, Washington
Anna Sureda, Barcelona, Spain
Klaus Tanner, Heidelberg, Germany
Andreas Trumpp, Heidelberg, Germany
Christof von Kalle, Heidelberg, Germany
Jean Wang, San Diego, California
Karl Welte, Hannover, Germany
Joachim Wittbrodt, Heidelberg, Germany
Mathias Witzens-Harig, Heidelberg, Germany
It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms: 1 altering the financial relationship with the commercial interest, 2 altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3 validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose will be disqualified from participating in the CME activity. |
